Psagot Value Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11
| Closed | -$1K | – | 376 |
|
|
2023
Q4 | $1K | Sell |
11
-11
| -50% | -$1K | ﹤0.01% | 505 |
|
|
2023
Q3 | $3K | Sell |
22
-8
| -27% | -$1.09K | ﹤0.01% | 420 |
|
|
2023
Q2 | $3K | Buy |
30
+4
| +15% | +$400 | ﹤0.01% | 399 |
|
|
2023
Q1 | $3K | Buy |
+26
| New | +$3K | ﹤0.01% | 379 |
|
|
2021
Q2 | – | Sell |
-205,473
| Closed | -$20M | – | 482 |
|
|
2021
Q1 | $20M | Hold |
205,473
| – | – | 0.45% | 62 |
|
|
2020
Q4 | $19.7M | Buy |
205,473
+69,464
| +51% | +$6.66M | 0.46% | 59 |
|
|
2020
Q3 | $13.1M | Buy |
+136,009
| New | +$13.1M | 0.33% | 73 |
|